238 related articles for article (PubMed ID: 11096748)
21. Clinical risk factors for the development of tardive dyskinesia.
Solmi M; Pigato G; Kane JM; Correll CU
J Neurol Sci; 2018 Jun; 389():21-27. PubMed ID: 29439776
[TBL] [Abstract][Full Text] [Related]
22. Tardive dyskinesia.
Gerlach J; Casey DE
Acta Psychiatr Scand; 1988 Apr; 77(4):369-78. PubMed ID: 2898870
[TBL] [Abstract][Full Text] [Related]
23. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 3: Clinical Trial Data.
Preskorn SH; Macaluso M
J Psychiatr Pract; 2016 Mar; 22(2):117-23. PubMed ID: 27138080
[TBL] [Abstract][Full Text] [Related]
24. Identification and management of tardive dyskinesia: A case series and literature review.
Khouzam HR
Postgrad Med; 2015; 127(7):726-37. PubMed ID: 26216578
[TBL] [Abstract][Full Text] [Related]
25. Coexistent tardive dyskinesia and parkinsonism.
Jankovic J; Casabona J
Clin Neuropharmacol; 1987 Dec; 10(6):511-21. PubMed ID: 2892586
[TBL] [Abstract][Full Text] [Related]
26. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
Soares-Weiser K; Rathbone J
Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
[TBL] [Abstract][Full Text] [Related]
27. The current status of tardive dyskinesia.
Sachdev PS
Aust N Z J Psychiatry; 2000 Jun; 34(3):355-69. PubMed ID: 10881961
[TBL] [Abstract][Full Text] [Related]
28. The nosology of tardive syndromes.
Frei K; Truong DD; Fahn S; Jankovic J; Hauser RA
J Neurol Sci; 2018 Jun; 389():10-16. PubMed ID: 29433810
[TBL] [Abstract][Full Text] [Related]
29. Valbenazine for the treatment of tardive dyskinesia.
Seeberger LC; Hauser RA
Expert Opin Pharmacother; 2017 Aug; 18(12):1279-1287. PubMed ID: 28699794
[TBL] [Abstract][Full Text] [Related]
30. Historical perspectives on tardive dyskinesia.
Caroff SN; Ungvari GS; Cunningham Owens DG
J Neurol Sci; 2018 Jun; 389():4-9. PubMed ID: 29454494
[TBL] [Abstract][Full Text] [Related]
31. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.
Morgenstern H; Glazer WM
Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845
[TBL] [Abstract][Full Text] [Related]
32. Pathophysiological mechanisms underlying tardive dyskinesia.
Gerlach J
Psychopharmacology Suppl; 1985; 2():98-103. PubMed ID: 2860666
[TBL] [Abstract][Full Text] [Related]
33. Managing antipsychotic-induced acute and tardive dystonia.
Raja M
Drug Saf; 1998 Jul; 19(1):57-72. PubMed ID: 9673858
[TBL] [Abstract][Full Text] [Related]
34. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 4: Case Report Data.
Macaluso M; Flynn A; Preskorn S
J Psychiatr Pract; 2016 May; 22(3):203-20. PubMed ID: 27123800
[TBL] [Abstract][Full Text] [Related]
35. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
[TBL] [Abstract][Full Text] [Related]
36. The natural history of tardive dystonia. A long-term follow-up study of 107 cases.
Kiriakakis V; Bhatia KP; Quinn NP; Marsden CD
Brain; 1998 Nov; 121 ( Pt 11)():2053-66. PubMed ID: 9827766
[TBL] [Abstract][Full Text] [Related]
37. Managing antipsychotic-induced tardive dyskinesia.
Gardos G
Drug Saf; 1999 Feb; 20(2):187-93. PubMed ID: 10082074
[TBL] [Abstract][Full Text] [Related]
38. Preventing neuroleptic-induced tardive dyskinesia in adults and children.
Lam RW; Jeste SD; Jeste DV
Encephale; 1988 Sep; 14 Spec No():251-5. PubMed ID: 2905652
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Tardive Dyskinesia.
Bashir HH; Jankovic J
Neurol Clin; 2020 May; 38(2):379-396. PubMed ID: 32279716
[TBL] [Abstract][Full Text] [Related]
40. Affective disorders and tardive dyskinesia.
Casey DE
Encephale; 1988 Sep; 14 Spec No():221-6. PubMed ID: 2905650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
